Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5-day Clarithromycin ER vs 7-day IR in ABECB
NCT00645086Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Dec 2002
- Primary completion
- Apr 2004
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of clarithromycin in chronic bronchitis (CB), sponsored by Abbott Laboratories. Started Dec 2002; status: completed.
02
Drugs
clarithromycin
03
Conditions
chronic bronchitis (CB)
Beyond the preview
Go deeper on NCT00645086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00645086.